Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Tock Han Lim"'
Publikováno v:
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background The EVEREST II study reported superior polyp closure rates and visual outcomes using combination standard photodynamic therapy (PDT) with intravitreal ranibizumab in the treatment of polypoidal choroidal vasculopathy (PCV). The op
Externí odkaz:
https://doaj.org/article/df860fc6c5ab4bf2990fa1c924937aed
Autor:
Eliza Xin Pei Ho, Chui Ming Gemmy Cheung, Shuzhen Sim, Collins Wenhan Chu, Andreas Wilm, Clarabelle Bitong Lin, Ranjana Mathur, Doric Wong, Choi Mun Chan, Mayuri Bhagarva, Augustinus Laude, Tock Han Lim, Tien Yin Wong, Ching Yu Cheng, Sonia Davila, Martin Hibberd
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201768 (2018)
BACKGROUND:While the aetiology of age-related macular degeneration (AMD)-a major blinding disease-remains unknown, the disease is strongly associated with variants in the complement factor H (CFH) gene. CFH variants also confer susceptibility to inva
Externí odkaz:
https://doaj.org/article/1191dcdac2eb4906a14e65aa192c6d13
Publikováno v:
Indian Journal of Ophthalmology, Vol 63, Iss 6, Pp 516-523 (2015)
Purpose: To determine if providing high dose anti-oxidant vitamins and zinc treatment age-related eye disease study (AREDS formulation) to patients with intermediate age-related macular degeneration (AMD) aged 40-79 years from Singapore is cost-effec
Externí odkaz:
https://doaj.org/article/d1018cd7fd63438ea48c2929d61f24e1
Autor:
Chin, Yi Yao Brendan, Tun Hang Yeo, Bakthavatsalu, Maheshwar, Wen Ting Zhou, Wagle, Ajeet Madhav, Lekha Gopal, Tock Han Lim
Publikováno v:
Retinal Cases & Brief Reports; Mar2024, Vol. 18 Issue 2, p155-158, 4p
Autor:
Colin S, Tan, Chui Ming, Gemmy Cheung, Timothy Y Y, Lai, Ramune, Pataluskaite, Philippe, Margaron, Tock Han, Lim
Publikováno v:
Retina. 42:2091-2098
To evaluate the predictors of complete polypoidal lesion regression (CPREG) in polypoidal choroidal vasculopathy.Post hoc analysis of EVEREST II-a 24-month, multicenter, randomized, controlled clinical trial of 322 patients with polypoidal choroidal
Autor:
Jeremy Liu, Rita Laiginhas, Federico Corvi, Frederick L. Ferris, Tock Han Lim, Srinivas R. Sadda, Nadia K. Waheed, Prashanth G. Iyer, Mengxi Shen, Yingying Shi, Omer Trivizki, Liang Wang, Elizabeth A. Vanner, William J. Feuer, Giovanni Gregori, Philip J. Rosenfeld
Publikováno v:
Ophthalmol Retina
PURPOSE: A training exercise was performed to study the ability of graders to reliably identify precursor lesions to geographic atrophy (GA), known as persistent choroidal hyper-transmission defects (hyperTDs), using en face optical coherence tomogra
Autor:
Yi Yao Brendan Chin, Tun Hang Yeo, Bakthavatsalu Maheshwar, Wen Ting Zhou, Wagle Madhav Ajeet, Gopal Lekha, Tock Han Lim
Publikováno v:
RETINAL Cases & Brief Reports.
Publikováno v:
Malaysian Journal of Ophthalmology. 2:165-170
Autor:
Sandra Liakopoulos, David Sarraf, Tock Han Lim, Emily Y. Chew, Frank G. Holz, K. Bailey Freund, Francesco Viola, Juan E. Grunwald, Philip J. Rosenfeld, Monika Fleckenstein, Ferdinando Bottoni, Srinivas R. Sadda, Adnan Tufail, Usha Chakravarthy, Alan C. Bird, Karl G. Csaky, Robyn H. Guymer, Giovanni Staurenghi, Victor Chong, Daniel Pauleikhoff, Sergio Pagliarini, Christine A. Curcio, Barbara A Blodi, Richard F. Spaide, Steffen Schmitz-Valckenberg, Janet R. Sparrow, Glenn J. Jaffe, Ramin Tadayoni, Jordi Monés, Jerry Lutty
Publikováno v:
Ophthalmology. 127:394-409
Purpose To describe the defining features of incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA), a consensus term referring to the OCT-based anatomic changes often identified before the development of complete RPE and outer
Autor:
Ling-Jun Li, Petrina Tan, Owen Hee, Rupesh Agrawal, Tock-Han Lim, Tien-Yin Wong, Stephen C Teoh
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 90(2)
Longitudinal evidence on retinal microvasculature and subsequent systemic inflammatory alteration is lacking. We investigated the association between retinal microvasculature and immune response among patients with HIV/AIDS over a 9-month antiretrovi